This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Paul Sirajuddin: Innovator in Cancer Treatment Strategies
Introduction
Paul Sirajuddin is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent work. His dedication to improving therapeutic strategies for cancer patients is evident in his latest patent.
Latest Patents
Paul Sirajuddin holds a patent titled "Combinatory treatment strategies of cancer based on RNA polymerase I inhibition." This patent discloses compositions that comprise a combination of at least one Pol I inhibitor, and at least one autophagy inhibiting compound, and/or at least one ACAT1 inhibiting compound, and/or at least one PARP inhibiting compound. These compositions are designed for use in treating cancers and other related neoplastic diseases, potentially including additional chemotherapeutic agents. He has 1 patent to his name.
Career Highlights
Paul is affiliated with The Johns Hopkins University, where he continues to advance his research in cancer treatment. His work is characterized by a commitment to developing effective therapeutic strategies that can significantly impact patient outcomes.
Collaborations
Throughout his career, Paul has collaborated with esteemed colleagues, including Marikki Laiho and Hester Hui Liu. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer treatments.
Conclusion
Paul Sirajuddin's contributions to cancer treatment through his innovative patent work exemplify his commitment to advancing medical science. His research continues to pave the way for new therapeutic strategies that may improve the lives of cancer patients.